Hillevax Stock Performance
| HLVX Stock | USD 1.97 0.02 1.01% |
Hillevax has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.24, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Hillevax are expected to decrease at a much lower rate. During the bear market, Hillevax is likely to outperform the market. Hillevax right now retains a risk of 2.24%. Please check out Hillevax maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Hillevax will be following its current trending patterns.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Hillevax are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Hillevax may actually be approaching a critical reversion point that can send shares even higher in March 2025. ...more
1 | Disposition of 2736234 shares by Frazier Life Sciences X, L.p. of Hillevax at 13.6 subject to Rule 16b-3 | 11/01/2024 |
2 | HilleVax GAAP EPS of -0.52 misses by 0.10 | 11/07/2024 |
3 | Discretionary transaction by David Socks of tradable shares of Hillevax subject to Rule 16b-3 | 12/04/2024 |
| Begin Period Cash Flow | 281 M |
Hillevax |
Hillevax Relative Risk vs. Return Landscape
If you would invest 190.00 in Hillevax on November 2, 2024 and sell it today you would earn a total of 9.00 from holding Hillevax or generate 4.74% return on investment over 90 days. Hillevax is currently generating 0.1015% in daily expected returns and assumes 2.2353% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than Hillevax, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Hillevax Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hillevax's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Hillevax, and traders can use it to determine the average amount a Hillevax's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0454
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | HLVX | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.24 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Hillevax is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hillevax by adding it to a well-diversified portfolio.
Hillevax Fundamentals Growth
Hillevax Stock prices reflect investors' perceptions of the future prospects and financial health of Hillevax, and Hillevax fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hillevax Stock performance.
| Return On Equity | -0.62 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | (65.22 M) | ||||
| Shares Outstanding | 49.81 M | ||||
| Price To Book | 0.54 X | ||||
| EBITDA | (132.47 M) | ||||
| Net Income | (123.57 M) | ||||
| Cash And Equivalents | 292.06 M | ||||
| Cash Per Share | 9.81 X | ||||
| Total Debt | 51.19 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 34.77 X | ||||
| Book Value Per Share | 3.82 X | ||||
| Cash Flow From Operations | (86.78 M) | ||||
| Earnings Per Share | (3.09) X | ||||
| Market Capitalization | 99.11 M | ||||
| Total Asset | 344.43 M | ||||
| Retained Earnings | (388.56 M) | ||||
| Working Capital | 281.41 M | ||||
About Hillevax Performance
Evaluating Hillevax's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Hillevax has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Hillevax has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.32) | (0.34) | |
| Return On Capital Employed | (0.49) | (0.46) | |
| Return On Assets | (0.32) | (0.34) | |
| Return On Equity | (0.54) | (0.51) |
Things to note about Hillevax performance evaluation
Checking the ongoing alerts about Hillevax for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hillevax help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hillevax may become a speculative penny stock | |
| Hillevax has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (123.57 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hillevax currently holds about 292.06 M in cash with (86.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.81, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 74.0% of the company shares are owned by institutional investors |
- Analyzing Hillevax's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hillevax's stock is overvalued or undervalued compared to its peers.
- Examining Hillevax's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hillevax's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hillevax's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hillevax's stock. These opinions can provide insight into Hillevax's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Hillevax Stock Analysis
When running Hillevax's price analysis, check to measure Hillevax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hillevax is operating at the current time. Most of Hillevax's value examination focuses on studying past and present price action to predict the probability of Hillevax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hillevax's price. Additionally, you may evaluate how the addition of Hillevax to your portfolios can decrease your overall portfolio volatility.